Drug Patents Come Under Fire in New House Bill

A new bill in Congress is proposing to alter the way drug patents are administered. The Terminating the Extension of Rights Misappropriated (TERM) Act, H.R. 3199, would require that any patents on a drug which were issued after the drug’s first patent would be presumed invalid when the first patent expires.

Friday The 13th Writer Puts Fear in Movie Producers

In a ruling that is spooking film producers, Victor Miller, the screenwriter behind the 1980 horror classic “Friday the 13th,” successfully convinced a federal judge in Connecticut that he was an independent contractor at the time he wrote the screenplay, and may be able to reclaim the copyright to it, which he assigned to the […]

Is Your Patent Safe From Government Agencies?

The Supreme Court held Monday that a federal agency may not challenge an issued patent. The case, Return Mail, Inc. v. U.S. Postal Service, involved a patent on a method of processing undeliverable mail, which the U.S. Postal Service challenged as merely an abstract idea under Alice, rather than a useful invention.